[Leu15]-Gastrin I (human)

[Leu15]-Gastrin I (human) is a synthetic peptide analog of the naturally occurring human gastrin hormone, distinguished by the substitution of leucine at position 15. This modification imparts unique biochemical properties, making it an invaluable tool for scientific research focused on gastrointestinal physiology, peptide-receptor interactions, and signal transduction pathways. As a member of the gastrin family, [Leu15]-Gastrin I plays a crucial role in modulating gastric acid secretion and influencing the growth of gastric mucosa. Its structural similarity to native human gastrin ensures that it retains the ability to interact with gastrin receptors, while the leucine substitution can provide insights into the structure-activity relationship and receptor selectivity. Researchers utilize this peptide to dissect the molecular mechanisms underlying gastrin-mediated cellular responses, facilitating the development of novel hypotheses in peptide hormone biology.

Gastrointestinal Physiology Research: In the study of gastrointestinal physiology, [Leu15]-Gastrin I serves as a powerful probe to elucidate the regulation of gastric acid secretion and the trophic effects on the gastric mucosa. By mimicking endogenous gastrin activity, it enables researchers to investigate the downstream signaling cascades that govern acid production, cellular proliferation, and differentiation within the stomach. Experimental models employing this peptide help clarify the role of specific amino acid residues in receptor binding affinity and activation, advancing our understanding of digestive system homeostasis.

Receptor Binding and Signal Transduction Studies: In receptor pharmacology, [Leu15]-Gastrin I is widely used to characterize the binding kinetics and specificity of gastrin/CCK-B receptors. The leucine substitution at position 15 offers a strategic advantage for dissecting the molecular determinants of ligand-receptor interactions. By comparing the binding profiles of this analog with native gastrin, researchers can identify critical contact points and conformational changes necessary for receptor activation. This information is instrumental in mapping the signal transduction pathways initiated by gastrin receptor engagement, supporting the rational design of new peptide analogs and antagonists.

Peptide Structure-Activity Relationship (SAR) Analysis: The unique sequence of [Leu15]-Gastrin I makes it an ideal candidate for structure-activity relationship studies. Researchers leverage this peptide to systematically assess how specific amino acid modifications influence biological activity, receptor selectivity, and metabolic stability. Such SAR investigations are pivotal for understanding the fundamental principles governing peptide hormone function and for guiding the synthesis of next-generation analogs with enhanced pharmacological properties. The insights gained from these studies contribute to the broader field of peptide chemistry and molecular pharmacology.

Gastrointestinal Cell Signaling Pathways: [Leu15]-Gastrin I is frequently employed in cell-based assays to probe the intracellular signaling events triggered by gastrin receptor activation. By monitoring second messenger production, kinase phosphorylation, and gene expression changes, scientists can delineate the complex network of pathways that mediate the physiological effects of gastrin. This approach enables the identification of novel regulatory nodes and potential therapeutic targets within the gastrointestinal tract, fostering innovation in the study of hormone-regulated cellular processes.

Peptide-Based Drug Discovery: In the context of drug discovery, [Leu15]-Gastrin I provides a valuable template for the development of peptide-based therapeutics and research tools. The knowledge gained from its application in receptor binding, SAR, and signaling studies informs the rational design of new peptides with tailored biological activities. By serving as a model compound, it accelerates the identification and optimization of lead candidates for further preclinical evaluation. Through these diverse applications, [Leu15]-Gastrin I (human) continues to support cutting-edge research in peptide science, gastrointestinal biology, and molecular pharmacology, driving advancements in our understanding of hormone action and receptor modulation.

1. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics